FDA

5 things to know in life sciences: Week of Feb. 2, 2026

The FDA launches domestic drug manufacturing precheck program. This and more in this week’s life sciences industry update. … READ MORE >

Three technologies shaping biotech in 2026. This and more in this week’s life sciences update. … READ MORE >

Biotech CEOs show cautious optimism for 2026. This and more in this week’s life sciences industry update. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

The FDA moves to speed up biosimilar approvals to cut drug costs. This and more in this week’s life sciences update. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

FDA launches pilot to boost domestic generic drug production. This and more in this week’s life sciences update. … READ MORE >

Heart devices lead medtech’s summer financing surge. This and more in this week’s life sciences update. … READ MORE >

Biotech IPOs in the U.S. have hit a six-month drought. This and more in this week’s life sciences update. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >